The Deputy Attorney General in the state of Nevada Christopher Eccles told MMAJunkie.com that UFC fighters Kevin Casey and Robert Drysdale flunked their post-fight drug tests. The UFC released a statement confirming the announcement.
The UFC has been notified by the Nevada State Athletic Commission that UFC middleweight Kevin Casey and light heavyweight Robert Drysdale failed drug tests following their fights at UFC 175 and The Ultimate Fighter Finale, respectively. Casey tested positive for drostanolone and Drysdale was flagged for an elevated testosterone-to-epitestosterone ratio. Both fighters have been temporarily suspended from competition and informed their positive tests violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes and will support the NSAC’s determination pending a formal hearing at a later date.
Casey made his UFC return at UFC 175 defeating Bubba Bush in just 61 seconds. The middleweight, after competing in “The Ultimate Fighter 17” losing to Josh Samman at the TUF 17 Finale was released after the loss. “King” then went to the regional circuit, even winning the RFA middleweight title.
Drysdale beat Keith Berish at The Ultimate Fighter 19 Finale, had an elevated testosterone-to-epitestosterone (T/E) ratio of 12:1, which is two times the allotted ratio of 6:1. This is the second time that Drysdale has failed a drug test for elevated testosterone-to-epitestosterone (T/E) ratio in the state of Nevada. Drysdale wasn’t allowed to compete at UFC 167 in November of 2013 by the Nevada State Athletic Commission due to an elevated T/E ratio of 19.4:1.
Echols also stated that all fighters from UFC 175 were subject to enhanced testing of blood and urine, while the TUF 19 Finale competitors were only subjected to a urine test.